School of Medicine
Showing 12,351-12,400 of 12,941 Results
-
Yingcheng Wu
Visiting Postdoctoral Scholar, Pathology
Affiliate, Pathology Research Faculty PTAsBioYingcheng (Charles) Wu is a researcher specializing in Agentic AI for Medicine, advised by Le Cong and Mengdi Wang. Charles has published studies in top-tier journals including Cell, Science, Nature, and Cancer Discovery, and is a recipient of the ICIS Sidney & Joan Pestka Award, the IUBMB Young Scientist Program Fellowship, and the APASL Young Investigator Award.
-
Yue Wu
Postdoctoral Scholar, Genetics
Current Research and Scholarly InterestsI built computational methods to integrate and model biological time series, including metabolic dynamics, longitudinal multi-omics data, and micro-sampling. I reduce dimensions, built clusters, and search for causal links.
-
Courtney Wusthoff, MD
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsMy projects focus on clinical research in newborns with, or at risk, for brain injury. I use EEG in at-risk neonates to better understand the underlying pathophysiology of risk factors that may lead to worse outcomes. I am particularly interested in neonatal seizures and how they may exacerbate perinatal brain injury with a goal to identify treatments that might protect the vulnerable brain. I am also interested in EEG in other pediatric populations, as well as medical ethics and global health.
-
Joanna Wysocka
Lorry Lokey Professor and Professor of Developmental Biology
Current Research and Scholarly InterestsThe precise and robust regulation of gene expression is a cornerstone for complex biological life. Research in our laboratory is focused on understanding how regulatory information encoded by the genome is integrated with the transcriptional machinery and chromatin context to allow for emergence of form and function during human embryogenesis and evolution, and how perturbations in this process lead to disease.
-
Tony Wyss-Coray, PhD
D. H. Chen Professor II
Current Research and Scholarly InterestsUse of genetic and molecular tools to dissect immune and inflammatory pathways in Alzheimer's and neurodegeneration.
-
Jinxi Xiang
Postdoctoral Scholar, Radiation Physics
Current Research and Scholarly InterestsI develop machine leanring methods to autonomate the digital pathology.
-
Haopeng Xiao
Assistant Professor of Biochemistry
BioUnderstanding mechanisms of metabolic regulation in physiology and disease forms the basis for developing therapies to treat diseases in which metabolism is perturbed. We devise novel mass spectrometry (MS)-based proteomics technologies, combined with data science, to systematically discover mechanisms of metabolic regulation over protein function. Our strategies established the first tissue-specific landscape of protein cysteine redox regulation during aging, elucidating mechanisms of redox signaling in physiology that remained elusive for decades. We also leverage the genetic diversity of outbred populations to systematically annotate protein function and protein-metabolite co-regulation. The aim of our research program is to develop next-generation MS-based strategies to understand mechanisms of metabolic regulation in aging, metabolic disease, and cancer, and to use this knowledge as a basis to develop translational therapeutics.
-
Yuyin Xiao
Postdoctoral Scholar, Economics
BioYuyin Xiao is the postdoctoral researcher of the Freeman Spogli Institute for International Studies at Stanford University. She received her MS and PhD from Shanghai Jiaotong University. Her research focuses almost exclusively on low- and middle-income countries and is concerned with: health policy, including health equity, supply, demand and utilization of health service programs, and research on health service systems; health technology and innovation, including digital health, development of digital health tools, and evaluation of the effectiveness of digital interventions. Yuyin’s papers have been published in leading academic journals, including British Medical Journal, Journal of Medical Internet Research, Journal of Biomedical Informatics, BMC Public Health and others.
-
Zhen Xiao
Postdoctoral Scholar, Molecular Imaging Program at Stanford
Current Research and Scholarly InterestsApplying magnetic nanomaterials for bioimaging and cancer treatment
-
James Xie
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Associate Professor, Clinical InformaticsBioDr. James Xie is a board certified pediatrician, pediatric anesthesiologist, and clinical informaticist at Stanford University School of Medicine. His goal is to improve patient care and promote health equity with health information technologies. Currently he serves as a clinical informaticist and Epic physician builder at Stanford Medicine Children's Health. He holds additional appointments in the Division of Obstetric Anesthesiology and Maternal Health and Division of Clinical Informatics.
Dr. Xie studied computer science and medicine at Stanford University, followed by a combined residency in general pediatrics at Boston Children's Hospital and Boston Medical Center and anesthesiology at Brigham and Women's Hospital. After residency, he completed a fellowship in pediatric anesthesiology at Stanford Children's Health where he subsequently joined the faculty. -
Min Xie
Postdoctoral Fellow, Medicine - Primary Care and Population Health
BioCausal inference using natural experiments with focuses on public health policy and medical intervention.
Also work on development economics topics of financial and education intervention.
PhD in economics, Heidelberg University
personal webpage: https://minxie.org -
Lei Xing
Jacob Haimson and Sarah S. Donaldson Professor and Professor, by courtesy, of Electrical Engineering
Current Research and Scholarly Interestsartificial intelligence in medicine, medical imaging, Image-guided intervention, molecular imaging, biology guided radiation therapy (BGRT), treatment plan optimization
-
Xiaojing Xing
Masters Student in Clinical Informatics Management, admitted Summer 2025
BioXiaojing Xing is a health tech founder and product leader working at the intersection of medicine, business, and technology. She has driven AI-powered innovations across hardware and software—building from MVP to scale at both startups and global tech companies.
At Tencent, she led digital health platforms serving over 30 million users and launched AI tools that empowered 200,000+ physicians. Later, as Chief Product Officer at MindLax, she brought a neurofeedback sleep device from concept to market, growing it to thousands of users through data-driven iteration and user empathy.
Recognized on Forbes 30 Under 30 China, Xiaojing blends product management, global go-to-market strategy, and health innovation expertise. She is currently focused on applying AI to consumer health—creating intelligent, accessible technologies that make wellbeing part of everyday life.
Xiaojing holds degrees from Stanford University School of Medicine, Harvard T.H. Chan School of Public Health, and Peking University Health Science Center. -
Lulu Xing
Affiliate,
BioLulu received her undergraduate degree in Biomedicine from the University of Melbourne in Melbourne, Australia. In December 2016, Lulu was awarded a PhD degree in neuroscience from the Florey Institute of Neuroscience and Mental Health, the University of Melbourne, where she identified a major under-appreciated role for subventricular zone-derived neural precursor cells in the process of myelin regeneration after demyelinating injury. Since late 2016, Lulu worked at Australian Regenerative Medicine Institute, Monash University as a postdoctoral fellow in Dr. Tobias Merson’s group, with a focus on developing mouse models to study the molecular and cellular mechanisms underlying myelination mediated by distinct types of endogenous brain stem cells in health and disease. In particular, Lulu developed a novel mouse model of conditional OPC ablation, which could be adopted in different neurological contexts to further advance our knowledge and understanding of OPC biology. Lulu joined the Petritsch lab in late October 2022 as a research scientist, seeking to understand the role of OPCs in the development of glioma as tumour-initiating cells and how they are regulated by complex interactions with several cell types within the tumour microenvironment, using a combination of transgenic mouse models, advanced imaging techniques and single cell biology approaches.
